References
- Australian Bureau of Statistics Regional Population Growth, Australia 2015–2016 2017 (cited 2017 30/03/2017).
- Nik-Zainal, S, et al. 2016 Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature, 534(7605): 47–54. DOI: 10.1038/nature17676
- Al-Ejeh, F, et al. 2014 Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer. Oncotarget, 5(10): 3145–58. DOI: 10.18632/oncotarget.1865
- Vargas, A C, et al. 2012 Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat, 135(1): 153–65. DOI: 10.1007/s10549-012-2123-4
- Wiegmans, A P, et al. 2014 Rad51 supports triple negative breast cancer metastasis. Oncotarget, 5(10): 3261–72. DOI: 10.18632/oncotarget.1923
- McCart Reed, A E, et al. 2013 Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer. Virchows Archiv: An International Journal of Pathology, 463(4): 535–45. DOI: 10.1007/s00428-013-1468-3
- Bojesen, S E, et al. 2013 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet, 45(4): 371–84, 384e1–2. DOI: 10.1038/ng.2566
- Johnston, R L, et al. 2016 High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations. Breast Cancer Res, 18(1): 18. DOI: 10.1186/s13058-016-0681-9
- Saunus, J M, et al. 2015 Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance. J Pathol, 237(3): 363–378. DOI: 10.1002/path.4583
- Carpenter, J, et al. 2014 The Australian Breast Cancer Tissue Bank (ABCTB). Open Journal of Bioresources, 1: e1. DOI: 10.5334/ojb.aa